Status:
COMPLETED
Evaluation of ApneaLink Plus Scoring Capabilities
Lead Sponsor:
ResMed
Conditions:
Sleep Apnea, Central
Sleep Apnea, Obstructive
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the following topics: * Determine the accuracy of ApneaLink Plus in separating Apneas into Obstructive Apneas, Mixed Apneas and Central Apneas. * Determine...
Detailed Description
* Determine the accuracy of ApneaLink Plus in separating Apneas into Obstructive Apneas, Mixed Apneas and Central Apneas. * Determine the accuracy of ApneaLink Plus in scoring Hypopneas according to t...
Eligibility Criteria
Inclusion
- Willing to give written informed consent
- Adult patients who are 18 years of age or older
- No alcohol consumption 12 hrs before and during the trial period
- Normally sleep more than 3 hours per night
Exclusion
- Unable to comprehend written and spoken German.
- Pregnant
- Patients who use of Bilevel PAP or CPAP therapy during the PSG
- Unsuitable for inclusion in the opinion of the investigator
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00823134
Start Date
December 1 2008
End Date
March 1 2009
Last Update
May 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Klinik für Atemwegserkrankungen und Allergien, Fachkliniken Wangen
Wangen, Baden-Wurttemberg, Germany, 88239